Aicardi syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:50OMIM:304050Q04.0
Who is this for?
Show terms as
1Active trials20Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Aicardi syndrome is a rare neurodevelopmental disorder that occurs almost exclusively in females and is characterized by a classic triad of features: agenesis (partial or complete absence) of the corpus callosum, infantile spasms (a type of seizure), and distinctive chorioretinal lacunae (lesions in the light-sensitive tissue at the back of the eye). The condition is thought to result from a de novo mutation on the X chromosome, and it is believed to be lethal in males, which explains why nearly all affected individuals are female, with rare exceptions in males with Klinefelter syndrome (47,XXY). The specific causative gene has not yet been identified. Aicardi syndrome primarily affects the brain, eyes, and skeletal system. In addition to the classic triad, affected individuals frequently exhibit other brain malformations such as cortical heterotopias, polymicrogyria, and intracranial cysts (including choroid plexus papillomas). Ocular abnormalities may include microphthalmia, optic nerve colobomas, and optic disc anomalies. Skeletal features can include costovertebral anomalies such as hemivertebrae and absent or fused ribs. Intellectual disability is typically severe, and epilepsy is often refractory to standard antiepileptic medications. Some individuals may also develop skin lesions. There is currently no cure for Aicardi syndrome, and treatment is primarily supportive and symptomatic. Management focuses on seizure control, which can be challenging and may require multiple antiepileptic drugs, dietary therapies such as the ketogenic diet, or in some cases surgical interventions. Physical therapy, occupational therapy, and early intervention programs are important to optimize developmental outcomes. Regular ophthalmologic and neurological follow-up is essential. Prognosis varies considerably, but many individuals survive into childhood and adolescence, with some living into adulthood, though significant neurodevelopmental impairment is typical.

Also known as:

Clinical phenotype terms— hover any for plain English:

Optic disc colobomaHP:0000588Bifid ribsHP:0000892Rib fusionHP:0000902Missing ribsHP:0000921
Inheritance

X-linked dominant

Carried on the X chromosome; a single copy can cause the condition

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

1 event
Oct 2002Study of Selected X-Linked Disorders: Aicardi Syndrome

Baylor College of Medicine

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Aicardi syndrome.

1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

1 recruitingView all trials with filters →
Other1 trial
Study of Selected X-Linked Disorders: Aicardi Syndrome
Actively Recruiting
PI: Ignatia B Van den Veyver, MD (Baylor College of Medicine) · Sites: Houston, Texas

Specialists

20 foundView all specialists →
PP
Philippe KAHANE, MD, PUPH
Specialist
PI on 1 active trial
CM
Ching Moey
Specialist
1 Aicardi syndrome publication
SM
Simone A Mandelstam
Specialist
1 Aicardi syndrome publication
AG
Alison E Gardner
Specialist
1 Aicardi syndrome publication
JG
Jozef Gecz
Specialist
2 Aicardi syndrome publications
SM
Silvia Masnada
Specialist
2 Aicardi syndrome publications
VG
Valentina De Giorgis
Specialist
2 Aicardi syndrome publications
AP
Anna Pichiecchio
Specialist
2 Aicardi syndrome publications
PV
Pierangelo Veggiotti
Specialist
2 Aicardi syndrome publications
MW
Mayur Wanjari
Specialist
2 Aicardi syndrome publications
GM
Gaurav Mittal
Specialist
2 Aicardi syndrome publications
RP
Roshan Prasad
Specialist
2 Aicardi syndrome publications
TH
Thuong T Ha
Specialist
1 Aicardi syndrome publication
RB
Rosemary Burgess
Specialist
1 Aicardi syndrome publication
MN
Morgan Newman
Specialist
1 Aicardi syndrome publication
AM
Adeline Vanderver, MD
Los Angeles, California
Specialist

Rare Disease Specialist

PI on 4 active trials1 Aicardi syndrome publication
IM
Ignatia B Van den Veyver, MD
Specialist
PI on 3 active trials1 Aicardi syndrome publication
YC
Yanick Crow
Specialist
PI on 1 active trial32 Aicardi syndrome publications
SM
Stéphane BLANCHE, MD,PhD
Specialist
PI on 1 active trial
MF
Manuela Formica
Specialist
2 Aicardi syndrome publications

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Aicardi syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Aicardi syndromeForum →

No community posts yet. Be the first to share your experience with Aicardi syndrome.

Start the conversation →

Latest news about Aicardi syndrome

No recent news articles for Aicardi syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Aicardi syndrome

What is Aicardi syndrome?

Aicardi syndrome is a rare neurodevelopmental disorder that occurs almost exclusively in females and is characterized by a classic triad of features: agenesis (partial or complete absence) of the corpus callosum, infantile spasms (a type of seizure), and distinctive chorioretinal lacunae (lesions in the light-sensitive tissue at the back of the eye). The condition is thought to result from a de novo mutation on the X chromosome, and it is believed to be lethal in males, which explains why nearly all affected individuals are female, with rare exceptions in males with Klinefelter syndrome (47,XX

How is Aicardi syndrome inherited?

Aicardi syndrome follows a x-linked dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Aicardi syndrome typically begin?

Typical onset of Aicardi syndrome is neonatal. Age of onset can vary across affected individuals.

Are there clinical trials for Aicardi syndrome?

Yes — 1 recruiting clinical trial is currently listed for Aicardi syndrome on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Aicardi syndrome?

20 specialists and care centers treating Aicardi syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.